From monitoring NAIC working group votes on capital charges across the past three national meetings, a clear regulatory trajectory emerges: capital relief for well-documented performing assets alongside heightened scrutiny of structures that obscure underlying risk characteristics. The April 30, 2026 vote on residential mortgage loan RBC factors illustrates both sides of that pattern simultaneously.

The Life Risk-Based Capital (E) Working Group adopted Item 2026-02-L without a single dissenting vote, reducing the C-1 risk-based capital factor from 1.75% to 0.68% for life insurers investing in residential mortgage loans through unaffiliated joint ventures, partnerships, and limited liability companies. The new factor takes effect for December 31, 2026 RBC calculations, pending Capital Adequacy Task Force approval before the June 30 cutoff. That approval is widely expected, given the unanimous working group vote and the absence of formal opposition during the comment period.

The practical effect: a life insurer holding $1 billion in performing residential mortgage loans through an unaffiliated Schedule BA vehicle will see its required capital on that block drop from $17.5 million to $6.8 million, freeing $10.7 million for redeployment or surplus improvement. Scale that across an industry that held $117.4 billion in residential mortgage loans at year-end 2024, and the aggregate capital release becomes material enough to reshape allocation decisions across the sector.

What Changed and Why It Matters

The factor reduction corrects a structural inconsistency in the RBC framework. Before this vote, a life insurer that owned residential mortgage loans directly on its balance sheet and reported them on Schedule B received the favorable 0.68% C-1 factor. The same loans, held through an unaffiliated joint venture or LLC and reported on Schedule BA, carried a 1.75% factor for senior lien positions or 3.00% for non-senior liens. The difference had nothing to do with the credit quality of the underlying mortgages. It reflected the vehicle structure.

In 2024, the Working Group took a first step by extending look-through treatment to affiliated vehicles, allowing insurers to apply the 0.68% factor when the Schedule BA entity was under their control. The rationale was that affiliated structures gave insurers the ability to obtain detailed loan-level information and confirm that mortgages met the "in good standing" criteria.

The April 2026 vote extends that same treatment to unaffiliated vehicles. The Working Group concluded that the loan quality conditions, not the affiliation status of the holding entity, should determine the capital charge. If the underlying residential mortgage loans are current or fewer than 90 days delinquent, the vehicle qualifies for look-through treatment regardless of whether it is affiliated with the insurer.

Holding Structure Previous C-1 Factor New C-1 Factor (2026) Capital Per $1B
Direct ownership (Schedule B) 0.68% 0.68% (unchanged) $6.8M
Affiliated JV/LP/LLC (Schedule BA) 0.68% (since 2024) 0.68% (unchanged) $6.8M
Unaffiliated JV/LP/LLC (Schedule BA) 1.75% (senior lien) 0.68% $6.8M (was $17.5M)
Unaffiliated JV/LP/LLC (Schedule BA) 3.00% (non-senior lien) 0.68% (if in good standing) $6.8M (was $30.0M)
A1/A+ rated bond (comparison) 0.657% 0.657% $6.57M

The comparison to bond capital charges is instructive. At 0.68%, performing residential mortgage loans now carry a capital charge nearly identical to an A1/A+ rated bond at 0.657%. The Working Group's implicit position is that a portfolio of current residential mortgage loans, properly underwritten and monitored, presents a credit risk profile comparable to high-quality investment-grade corporate debt.

Conditions and Guardrails

The favorable factor comes with specific conditions that actuaries and investment teams need to build into their monitoring frameworks. The 0.68% treatment applies only when the following criteria are met:

  • Good standing requirement: Each residential mortgage loan must be current or fewer than 90 days past due. Loans that cross the 90-day threshold lose the favorable treatment.
  • Vehicle-level segregation: The Schedule BA entity must exclude delinquent mortgages from the pool qualifying for look-through treatment. If a vehicle holds both performing and non-performing loans, only the performing subset receives the 0.68% factor.
  • Residential classification: The look-through treatment applies to residential mortgage loans. Commercial mortgage loans held through the same vehicles continue under separate RBC categories (CM1 through CM5) with factors ranging from 0.40% to 6.50% based on loan-to-value and debt service coverage ratios.
  • Reporting compliance: Insurers must provide sufficient loan-level detail to demonstrate that the good-standing criteria are met at the reporting date.

These conditions create an ongoing monitoring obligation. Unlike a bond rating that changes infrequently, mortgage delinquency status can shift between reporting periods. Actuaries involved in asset adequacy testing should model the sensitivity of required capital to delinquency rate changes in the mortgage portfolio, particularly for large allocations where a wave of 90-day delinquencies could trigger a sudden capital charge increase from 0.68% back to the vehicle-level default factor.

The Qualifying Statutory Trust Accounting Bridge

The RBC factor reduction arrives alongside a parallel change in statutory accounting that further simplifies mortgage reporting. The Statutory Accounting Principles Working Group (SAPWG) amended SSAP No. 37 to permit look-through treatment for residential mortgage loans held through qualifying statutory trusts. Under the new guidance, insurers can report these loans on Schedule B, the same schedule used for directly owned mortgages, rather than Schedule BA.

To qualify, a statutory trust must meet several criteria:

  • 100% beneficial interest: The insurer must own the entire beneficial interest in the trust, or in a multi-series trust, the entire beneficial interest in the series holding the mortgage loans.
  • Restricted asset holdings: The trust may hold only mortgage loans, cash, and real estate acquired through foreclosure. A single parcel of foreclosed property may be held through a single-member LLC, consistent with SSAP No. 40.
  • No commingling: Multi-investor vehicles where multiple parties own interests in the same trust or series are excluded. This requirement prevents the look-through from extending to commingled funds.

The effective date for the SSAP 37 amendments is January 1, 2027, though early adoption is permitted and some insurers have already elected to implement the guidance in their 2025 annual statements. Schedule B reporting codes for qualifying statutory trusts will be available starting with the 2026 year-end reporting cycle.

For actuaries, the combined effect of the RBC factor change and the SSAP 37 amendment means that a qualifying statutory trust holding performing residential mortgages will now receive the same capital and reporting treatment as directly owned loans. The structural wrapper becomes transparent to both the capital formula and the accounting framework.

Industry Mortgage Allocation Growth: The Numbers Behind the Trend

The capital relief lands in a market where life insurer appetite for residential mortgage loans has already accelerated sharply. Industry holdings more than quadrupled from $31.8 billion in 2020 to $117.4 billion at year-end 2024, according to NAIC annual statement data analyzed by Milliman. Residential mortgages grew from 11.2% to 14.9% of total mortgage loan holdings during 2024 alone.

Several forces are driving the trend. Persistently elevated interest rates have made mortgage lending attractive relative to tight corporate credit spreads. Life insurers with long-duration liabilities, particularly annuity writers, find residential mortgages offer a duration and yield profile that fits their asset-liability management needs. Private-label RMBS exposure increased 23% year-over-year in 2024, and agency-backed RMBS rose 14%, making them the two fastest-growing bond types in insurer portfolios.

Among PE-backed carriers, the growth has been even more pronounced. Athene, backed by Apollo Global Management, nearly doubled its residential mortgage loan portfolio from $11.8 billion to $21.9 billion in a single year. The acquisition of Foundation Home Loans added a $4.2 billion mortgage portfolio to Apollo's management. Athene also became the second-largest borrower in the Federal Home Loan Bank system, with $23.3 billion in FHLB advances at year-end 2025, a funding channel frequently used to support mortgage origination and warehousing.

Across the broader industry, total mortgage loan holdings (residential and commercial combined) represent 15% of life insurer general account assets, up from 12% five years ago. Private credit more broadly reached $849 billion on life insurer balance sheets in 2024, or 14% of total assets.

Year Industry Residential Mortgage Holdings Year-over-Year Change
2020 $31.8 billion Baseline
2021 $45.2 billion +42%
2022 $62.7 billion +39%
2023 $89.1 billion +42%
2024 $117.4 billion +32%

The Invested Assets Task Force: Scrutiny Grows Alongside Capital Relief

The same Spring 2026 National Meeting that set the stage for the mortgage RBC factor reduction also launched a new oversight mechanism. The Invested Assets (E) Task Force held its inaugural session in San Diego on March 22-25, with residential mortgage loans featured as the first asset class under examination.

Neuberger Berman presented to the Task Force on the residential mortgage loan asset class, covering major subsectors, why insurers are growing allocations, underwriting approaches, and key risk factors. The presentation was met with what J.P. Morgan Asset Management described as "balanced and curious questions from regulators," a characterization consistent with the Task Force's stated goal of engaging with industry to understand investment trends before prescribing regulatory responses.

The Investment Analysis Working Group, which coordinates with the Task Force, identified several focus areas for its mortgage workstream:

  • Insurer participation patterns: Which companies are growing mortgage allocations, how quickly, and through what structures.
  • Underwriting approaches: Whether insurer-originated or acquired mortgage portfolios meet the credit standards that the 0.68% factor implicitly assumes.
  • Loan structures: The range of vehicles and legal structures used to access mortgage exposure, including Delaware Statutory Trusts, JVs, and fund structures.
  • Performance monitoring: How insurers track ongoing credit quality and whether existing reporting frameworks capture deterioration in real time.

Wisconsin Insurance Commissioner Nathan Houdek, who chairs the Financial Condition Committee, noted that the residential mortgage asset class has "drawn attention as usage extends beyond its original regulatory scope." That framing suggests regulators view the rapid growth with a mix of acceptance and caution: performing mortgages deserve appropriate capital treatment, but the structures used to access them need ongoing examination.

Delaware Statutory Trusts: The Structure Under the Microscope

Delaware Statutory Trusts (DSTs) have emerged as a preferred vehicle for insurers seeking indirect residential mortgage exposure. Under Delaware law, DSTs permit multiple investors to hold fractional beneficial interests in real estate or related assets, creating a mechanism for insurers to gain exposure through pooled structures while maintaining legal separation from the underlying loans.

Regulators have flagged DSTs as an area requiring closer examination. The core concern is alignment: whether disclosure standards, capital treatment, and risk attributes remain consistent with regulatory intent as insurers expand their indirect mortgage exposure. DSTs that meet the qualifying statutory trust criteria under the amended SSAP No. 37 can move to Schedule B reporting, but multi-investor DSTs where multiple parties share interests in the same pool of loans cannot qualify for look-through treatment.

This distinction creates a two-tier landscape. Single-insurer DSTs that hold performing residential mortgages benefit from both the 0.68% RBC factor and the simplified Schedule B reporting. Multi-investor DSTs remain on Schedule BA, subject to the vehicle-level RBC treatment, and face the growing scrutiny of the Invested Assets Task Force.

For actuaries conducting asset adequacy testing, the treatment of the vehicle structure affects reserve adequacy conclusions. A block of mortgages reported on Schedule B with a 0.68% factor produces different surplus strain projections than the same mortgages on Schedule BA at 1.75%. Understanding which structures qualify for look-through treatment, and monitoring the criteria continuously, becomes a core actuarial function in companies with material mortgage allocations.

Connection to the CLO and Collateral Loan Capital Overhaul

The mortgage RBC factor reduction is one piece of a broader capital charge recalibration running in parallel at the NAIC. The Life RBC Working Group is simultaneously addressing CLO capital factors and collateral loan treatment, and the divergent trajectories across these asset classes reveal the regulators' framework for distinguishing between transparent, well-documented exposures and complex, opaque structures.

For CLOs, the Academy of Actuaries proposed C-1 factors that would raise below-investment-grade charges from 2.73% to as high as 70.82% for thin junior tranches. For collateral loans, Proposal 2025-16-L MOD rejected look-through treatment for loans backed by JV/LP/LLC equity interests, instead calibrating charges to loan-to-value ratios with a 20% generic haircut, resulting in proposed factors of 30% for equity-backed collateral loans and 45% for residual tranche-backed positions.

By contrast, performing residential mortgages receive capital relief. The pattern is consistent: assets where regulators can verify credit quality at the individual loan level receive favorable treatment. Assets where structural complexity, subordination mechanics, or opaque valuation methods make risk assessment difficult face higher charges and tighter scrutiny.

Asset Class Direction of Capital Charge Effective Date
Residential mortgages (unaffiliated vehicles) Down: 1.75% to 0.68% Year-end 2026 (pending CADTF)
CLOs (below investment grade) Up: 2.73% to 12.59%-70.82% Year-end 2026 or 2027
Collateral loans (equity-backed) Up: 6.8% to 30% Year-end 2027
Collateral loans (residual-backed) Up: 6.8% to 45% Year-end 2027

For PE-backed life insurers, the net effect depends on portfolio composition. Carriers with heavy CLO and collateral loan concentrations face substantial capital increases on those positions, only partially offset by the mortgage factor reduction. Carriers that have tilted toward residential mortgage lending as their primary alternative asset strategy receive a cleaner capital benefit.

Implications for PE-Backed Life Insurer Strategy

The lower mortgage RBC factor creates a clear capital incentive for life insurers, particularly those backed by private equity sponsors with existing real estate lending platforms. Consider the capital math for a $5 billion residential mortgage allocation held through an unaffiliated vehicle:

  • Previous required capital: $5 billion x 1.75% = $87.5 million
  • New required capital: $5 billion x 0.68% = $34.0 million
  • Capital freed: $53.5 million

That released capital can support additional asset origination, improve RBC ratios reported to regulators, or reduce the need for surplus contributions from parent companies. For PE sponsors that manage mortgage origination platforms alongside their insurance platforms, the alignment is particularly attractive: mortgage origination generates management fees, and the lower RBC charge on the insurance balance sheet reduces the capital cost of holding the resulting loans.

The risk, from a regulatory perspective, is that the capital relief accelerates allocations beyond what the current monitoring framework can handle. If insurer mortgage holdings continue growing at the 30-40% annual pace observed since 2020, the industry's $117.4 billion exposure could approach $200 billion by year-end 2027. At that scale, even a modest deterioration in credit quality during an economic downturn could produce capital volatility that the 0.68% factor does not contemplate.

This tension explains why the capital relief and the Invested Assets Task Force scrutiny are happening simultaneously. Regulators are comfortable with the credit risk of performing residential mortgages. They are less comfortable with the pace and structural complexity of the growth, particularly when it involves vehicles and intermediaries that may not provide the transparency the 0.68% factor assumes.

What Actuaries Should Do Now

The December 31, 2026 effective date, assuming Capital Adequacy Task Force approval by June 30, gives actuaries and investment teams approximately seven months to prepare. Key action items include:

  • Inventory unaffiliated mortgage vehicles: Identify all Schedule BA entities holding residential mortgage loans through unaffiliated JVs, partnerships, and LLCs. Map which qualify for look-through treatment under the new criteria and which do not.
  • Build delinquency monitoring: Establish or enhance real-time tracking of the 90-day delinquency threshold for each qualifying vehicle. A loan crossing that threshold moves from 0.68% to the vehicle-level default factor, and the capital impact needs to flow into RBC projections immediately.
  • Update asset adequacy models: Reflect the lower RBC factor in cash flow testing and asset adequacy analysis. Model the sensitivity of surplus to delinquency rate stress scenarios, particularly for insurers with concentrated mortgage allocations.
  • Evaluate qualifying statutory trust structures: Determine whether existing DSTs or other vehicles meet the SSAP No. 37 criteria for Schedule B reporting. The combined benefit of favorable RBC treatment and simplified reporting makes qualifying statutory trust status valuable.
  • Coordinate with the Invested Assets Task Force workstream: Stay current on the Task Force's mortgage-focused inquiries. Disclosure and reporting requirements may evolve as the Task Force deepens its examination of insurer mortgage practices.
  • Model cross-asset capital impact: For carriers also holding CLOs and collateral loans, integrate the mortgage factor reduction with the expected increases on those positions. The net capital effect depends on the relative sizes and structures of each allocation.

The Approval Timeline

The path from Working Group adoption to effective implementation runs through the Capital Adequacy (E) Task Force. The June 30, 2026 deadline is the critical checkpoint: RBC factor changes adopted by CADTF before that date take effect for December 31, 2026 calculations. The timeline for Item 2026-02-L is as follows:

  • April 30, 2026: Life RBC Working Group unanimously adopted the 0.68% factor for unaffiliated vehicles.
  • May-June 2026: Capital Adequacy Task Force review period. CADTF typically reviews and ratifies working group adoptions at its next scheduled meeting.
  • Before June 30, 2026: CADTF adoption required for the factor to apply to December 31, 2026 RBC filings.
  • December 31, 2026: First RBC calculation cycle using the new 0.68% factor for qualifying unaffiliated mortgage vehicles.

Given the unanimous working group vote and the relatively straightforward nature of the change (extending an existing treatment to a broader set of qualifying vehicles), the CADTF adoption is considered a formality by most observers. The industry should plan on the factor being available for year-end 2026 reporting.

Why This Matters

The mortgage RBC factor reduction is more than a technical recalibration. It is a regulatory endorsement of residential mortgage loans as a low-risk asset class for life insurer portfolios, provided they are performing and properly documented. By equating the capital treatment of mortgages held through unaffiliated vehicles with direct ownership, the NAIC is removing a structural barrier that penalized legitimate investment diversification.

At the same time, the Invested Assets Task Force's focus on mortgage exposure growth, DST structures, and reporting adequacy signals that capital relief is not a blank check. Regulators expect the transparency and monitoring capabilities that justify the favorable factor. Insurers that treat the lower capital charge as a license to grow aggressively without corresponding infrastructure for loan-level reporting and delinquency tracking will find themselves at odds with the regulatory intent.

From tracking these workstreams across three consecutive NAIC national meetings, the direction is clear: the era of uniform, blunt-instrument capital charges is ending. In its place, the NAIC is building a differentiated framework where capital requirements reflect the actual risk characteristics of the underlying assets, the transparency of the holding structures, and the quality of the insurer's monitoring practices. The mortgage factor change is the clearest illustration yet of how that framework rewards clarity and penalizes complexity.

Further Reading

Sources